| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methyl-CpG-Binding Protein 2 | 70 | 2023 | 291 | 16.840 |
Why?
|
| Rett Syndrome | 54 | 2023 | 262 | 16.010 |
Why?
|
| Spinocerebellar Ataxias | 50 | 2023 | 233 | 12.120 |
Why?
|
| Nerve Tissue Proteins | 67 | 2022 | 1491 | 6.880 |
Why?
|
| Neurons | 50 | 2023 | 2287 | 6.810 |
Why?
|
| Ataxin-1 | 57 | 2023 | 148 | 6.670 |
Why?
|
| Cerebellum | 35 | 2023 | 449 | 6.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 24 | 2023 | 622 | 5.340 |
Why?
|
| Mental Retardation, X-Linked | 12 | 2021 | 94 | 4.610 |
Why?
|
| Repressor Proteins | 26 | 2019 | 1664 | 3.450 |
Why?
|
| Disease Models, Animal | 74 | 2023 | 7222 | 3.260 |
Why?
|
| Mice | 163 | 2023 | 34495 | 3.240 |
Why?
|
| Nuclear Proteins | 46 | 2022 | 3343 | 3.140 |
Why?
|
| Animals | 200 | 2023 | 59536 | 2.940 |
Why?
|
| Nervous System Diseases | 8 | 2018 | 500 | 2.450 |
Why?
|
| Gene Expression Regulation | 24 | 2021 | 4053 | 2.290 |
Why?
|
| Purkinje Cells | 26 | 2023 | 143 | 2.210 |
Why?
|
| Nerve Degeneration | 6 | 2018 | 148 | 2.190 |
Why?
|
| Mice, Knockout | 47 | 2022 | 5710 | 2.020 |
Why?
|
| Brain | 34 | 2023 | 4113 | 2.010 |
Why?
|
| tau Proteins | 4 | 2023 | 216 | 1.910 |
Why?
|
| Behavior, Animal | 21 | 2021 | 709 | 1.880 |
Why?
|
| Respiratory Center | 3 | 2019 | 10 | 1.780 |
Why?
|
| Mice, Transgenic | 49 | 2023 | 4143 | 1.770 |
Why?
|
| Autistic Disorder | 8 | 2021 | 319 | 1.760 |
Why?
|
| DNA-Binding Proteins | 20 | 2021 | 4821 | 1.760 |
Why?
|
| Chromosomal Proteins, Non-Histone | 10 | 2004 | 362 | 1.750 |
Why?
|
| Ataxins | 38 | 2015 | 91 | 1.730 |
Why?
|
| Mutation | 51 | 2023 | 15179 | 1.710 |
Why?
|
| Motor Neurons | 4 | 2022 | 138 | 1.640 |
Why?
|
| Gene Deletion | 13 | 2021 | 1442 | 1.620 |
Why?
|
| Neurogenesis | 7 | 2021 | 238 | 1.570 |
Why?
|
| Motor Activity | 10 | 2021 | 693 | 1.500 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 4 | 2021 | 88 | 1.490 |
Why?
|
| Gene Expression Regulation, Developmental | 15 | 2020 | 1498 | 1.490 |
Why?
|
| Peptides | 23 | 2022 | 1479 | 1.490 |
Why?
|
| RNA Splicing | 4 | 2018 | 370 | 1.480 |
Why?
|
| Trinucleotide Repeat Expansion | 8 | 2021 | 132 | 1.460 |
Why?
|
| Protein Stability | 8 | 2021 | 370 | 1.460 |
Why?
|
| Mice, Inbred C57BL | 36 | 2021 | 6942 | 1.440 |
Why?
|
| Parkinson Disease | 7 | 2021 | 708 | 1.430 |
Why?
|
| Haploinsufficiency | 7 | 2020 | 294 | 1.410 |
Why?
|
| Deep Brain Stimulation | 5 | 2018 | 348 | 1.410 |
Why?
|
| Tauopathies | 2 | 2023 | 63 | 1.380 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2021 | 248 | 1.370 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2012 | 96 | 1.350 |
Why?
|
| Chromatin | 7 | 2023 | 942 | 1.340 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2020 | 5539 | 1.330 |
Why?
|
| Neuronal Plasticity | 10 | 2020 | 304 | 1.320 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 2023 | 19 | 1.310 |
Why?
|
| Brain Stem | 3 | 2021 | 175 | 1.310 |
Why?
|
| Awards and Prizes | 3 | 2015 | 98 | 1.280 |
Why?
|
| RNA Splicing Factors | 4 | 2018 | 153 | 1.280 |
Why?
|
| GABAergic Neurons | 2 | 2020 | 47 | 1.260 |
Why?
|
| RNA-Binding Proteins | 7 | 2018 | 984 | 1.250 |
Why?
|
| Autism Spectrum Disorder | 6 | 2020 | 363 | 1.250 |
Why?
|
| Cell Nucleus | 11 | 2018 | 1620 | 1.210 |
Why?
|
| alpha-Synuclein | 5 | 2021 | 118 | 1.190 |
Why?
|
| Rhombencephalon | 4 | 2014 | 44 | 1.180 |
Why?
|
| Alleles | 10 | 2023 | 2437 | 1.170 |
Why?
|
| Neuropeptides | 5 | 2019 | 154 | 1.160 |
Why?
|
| Phenotype | 34 | 2022 | 6295 | 1.090 |
Why?
|
| Gene Duplication | 8 | 2016 | 421 | 1.080 |
Why?
|
| RNA Interference | 4 | 2019 | 1408 | 1.080 |
Why?
|
| Developmental Disabilities | 7 | 2020 | 674 | 1.060 |
Why?
|
| Aging | 7 | 2023 | 1582 | 1.040 |
Why?
|
| Transcription, Genetic | 14 | 2019 | 3154 | 1.020 |
Why?
|
| Protein Structure, Tertiary | 10 | 2020 | 1487 | 0.990 |
Why?
|
| Synapses | 10 | 2022 | 509 | 0.970 |
Why?
|
| Phosphorylation | 24 | 2021 | 4804 | 0.970 |
Why?
|
| Intellectual Disability | 10 | 2019 | 1032 | 0.950 |
Why?
|
| Amacrine Cells | 1 | 2023 | 35 | 0.930 |
Why?
|
| Humans | 140 | 2023 | 261506 | 0.920 |
Why?
|
| Polyadenylation | 3 | 2020 | 70 | 0.920 |
Why?
|
| Cell Differentiation | 12 | 2023 | 4078 | 0.910 |
Why?
|
| Social Behavior | 8 | 2015 | 306 | 0.900 |
Why?
|
| Biomedical Research | 5 | 2015 | 806 | 0.890 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 2 | 2020 | 16 | 0.880 |
Why?
|
| Fornix, Brain | 3 | 2018 | 20 | 0.870 |
Why?
|
| Learning | 5 | 2021 | 403 | 0.870 |
Why?
|
| Drosophila melanogaster | 8 | 2021 | 829 | 0.870 |
Why?
|
| Gene Expression | 10 | 2016 | 3570 | 0.870 |
Why?
|
| Microfilament Proteins | 4 | 2019 | 487 | 0.860 |
Why?
|
| Neurodegenerative Diseases | 9 | 2018 | 264 | 0.860 |
Why?
|
| Serine | 11 | 2021 | 388 | 0.860 |
Why?
|
| Mortality, Premature | 1 | 2022 | 11 | 0.850 |
Why?
|
| Memory Disorders | 7 | 2022 | 295 | 0.850 |
Why?
|
| Gene Dosage | 7 | 2015 | 829 | 0.850 |
Why?
|
| Hypothalamus | 3 | 2009 | 255 | 0.850 |
Why?
|
| Transcription Factors | 14 | 2022 | 5270 | 0.820 |
Why?
|
| Protein Binding | 22 | 2022 | 3438 | 0.810 |
Why?
|
| Biomedical Enhancement | 1 | 2021 | 1 | 0.800 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 8 | 0.800 |
Why?
|
| Drosophila | 10 | 2023 | 839 | 0.800 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2012 | 82 | 0.790 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2021 | 44 | 0.780 |
Why?
|
| Mutation, Missense | 5 | 2019 | 1152 | 0.770 |
Why?
|
| Retina | 3 | 2023 | 532 | 0.760 |
Why?
|
| Dendritic Spines | 5 | 2021 | 59 | 0.750 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 2 | 2018 | 32 | 0.740 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 93 | 0.740 |
Why?
|
| Male | 71 | 2023 | 123000 | 0.730 |
Why?
|
| Hair Cells, Auditory | 2 | 2017 | 60 | 0.730 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 538 | 0.710 |
Why?
|
| Seizures | 5 | 2018 | 989 | 0.700 |
Why?
|
| 14-3-3 Proteins | 4 | 2021 | 143 | 0.700 |
Why?
|
| Neurosciences | 3 | 2010 | 53 | 0.690 |
Why?
|
| Mice, Mutant Strains | 6 | 2021 | 634 | 0.690 |
Why?
|
| Gene Expression Profiling | 14 | 2020 | 5159 | 0.690 |
Why?
|
| Fragile X Syndrome | 5 | 2014 | 150 | 0.690 |
Why?
|
| Cytoplasm | 5 | 2021 | 652 | 0.680 |
Why?
|
| Medulloblastoma | 2 | 2017 | 540 | 0.670 |
Why?
|
| Genes, Duplicate | 2 | 2015 | 21 | 0.670 |
Why?
|
| Mental Disorders | 5 | 2022 | 862 | 0.670 |
Why?
|
| Female | 73 | 2023 | 141928 | 0.670 |
Why?
|
| Hypercapnia | 1 | 2018 | 26 | 0.660 |
Why?
|
| Cells, Cultured | 12 | 2021 | 5637 | 0.660 |
Why?
|
| Nervous System | 2 | 2012 | 165 | 0.660 |
Why?
|
| Histones | 5 | 2020 | 1466 | 0.650 |
Why?
|
| Homeostasis | 5 | 2018 | 950 | 0.640 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 1399 | 0.640 |
Why?
|
| Hippocampus | 9 | 2022 | 915 | 0.630 |
Why?
|
| p21-Activated Kinases | 1 | 2018 | 122 | 0.630 |
Why?
|
| Neural Inhibition | 2 | 2016 | 147 | 0.630 |
Why?
|
| Somatostatin | 2 | 2015 | 114 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 280 | 0.610 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 310 | 0.610 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 1077 | 0.600 |
Why?
|
| MicroRNAs | 4 | 2020 | 2947 | 0.600 |
Why?
|
| Respiratory System | 1 | 2018 | 125 | 0.600 |
Why?
|
| Substance P | 1 | 2017 | 71 | 0.590 |
Why?
|
| Cell Lineage | 7 | 2021 | 668 | 0.580 |
Why?
|
| HEK293 Cells | 7 | 2021 | 1489 | 0.580 |
Why?
|
| Trinucleotide Repeats | 5 | 2019 | 106 | 0.570 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 40 | 0.570 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 803 | 0.570 |
Why?
|
| Sodium Channels | 1 | 2017 | 109 | 0.570 |
Why?
|
| Chromosomes, Human, X | 5 | 2009 | 192 | 0.570 |
Why?
|
| Protein Kinases | 3 | 2019 | 874 | 0.560 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2014 | 23 | 0.560 |
Why?
|
| Movement Disorders | 3 | 2017 | 232 | 0.560 |
Why?
|
| Memory | 5 | 2015 | 429 | 0.560 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 621 | 0.550 |
Why?
|
| Neurobiology | 2 | 2016 | 25 | 0.550 |
Why?
|
| Parvalbumins | 1 | 2015 | 30 | 0.550 |
Why?
|
| alpha Karyopherins | 1 | 2015 | 13 | 0.540 |
Why?
|
| Hearing Loss | 1 | 2017 | 153 | 0.540 |
Why?
|
| Glycoproteins | 1 | 2019 | 747 | 0.540 |
Why?
|
| Interneurons | 3 | 2022 | 144 | 0.540 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 71 | 0.530 |
Why?
|
| Sodium | 1 | 2017 | 353 | 0.530 |
Why?
|
| Membrane Proteins | 7 | 2020 | 2819 | 0.530 |
Why?
|
| Hypoxia | 1 | 2018 | 443 | 0.530 |
Why?
|
| Spinal Cord | 5 | 2018 | 690 | 0.520 |
Why?
|
| Immunization, Passive | 1 | 2015 | 172 | 0.520 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 156 | 0.510 |
Why?
|
| Genetic Testing | 5 | 2021 | 1589 | 0.510 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 330 | 0.510 |
Why?
|
| Periodicity | 2 | 2017 | 68 | 0.500 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 855 | 0.500 |
Why?
|
| Electrophysiology | 5 | 2021 | 333 | 0.500 |
Why?
|
| Pyramidal Cells | 3 | 2022 | 168 | 0.490 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 305 | 0.490 |
Why?
|
| DNA Methylation | 4 | 2018 | 2669 | 0.490 |
Why?
|
| Transcriptome | 6 | 2022 | 1859 | 0.490 |
Why?
|
| ras Proteins | 3 | 2021 | 770 | 0.490 |
Why?
|
| Mutant Proteins | 3 | 2019 | 234 | 0.480 |
Why?
|
| Disease | 1 | 2016 | 165 | 0.480 |
Why?
|
| Dosage Compensation, Genetic | 3 | 2005 | 63 | 0.480 |
Why?
|
| Subthalamic Nucleus | 1 | 2014 | 57 | 0.480 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2013 | 639 | 0.470 |
Why?
|
| Cell Line | 12 | 2021 | 5114 | 0.460 |
Why?
|
| Synaptic Transmission | 5 | 2020 | 443 | 0.460 |
Why?
|
| Anxiety | 4 | 2020 | 1179 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 287 | 0.460 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 679 | 0.460 |
Why?
|
| Intranuclear Inclusion Bodies | 3 | 2018 | 19 | 0.440 |
Why?
|
| Signal Transduction | 11 | 2021 | 11965 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2019 | 96 | 0.440 |
Why?
|
| X Chromosome | 5 | 2004 | 339 | 0.430 |
Why?
|
| Amino Acid Sequence | 11 | 2018 | 4233 | 0.420 |
Why?
|
| Stem Cells | 3 | 2008 | 1213 | 0.420 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 31 | 0.420 |
Why?
|
| Cell Movement | 5 | 2012 | 2466 | 0.420 |
Why?
|
| Carrier Proteins | 7 | 2020 | 2022 | 0.420 |
Why?
|
| Long-Term Potentiation | 5 | 2015 | 176 | 0.410 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 2 | 2013 | 12 | 0.410 |
Why?
|
| Intestines | 2 | 2007 | 686 | 0.410 |
Why?
|
| Threonine | 1 | 2012 | 161 | 0.410 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 2011 | 1 | 0.400 |
Why?
|
| Genomic Instability | 2 | 2005 | 519 | 0.400 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 86 | 0.400 |
Why?
|
| Carcinogenesis | 1 | 2017 | 1026 | 0.390 |
Why?
|
| Corticosterone | 2 | 2012 | 119 | 0.390 |
Why?
|
| Genes, Reporter | 7 | 2020 | 798 | 0.390 |
Why?
|
| RNA, Messenger | 14 | 2015 | 6150 | 0.390 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2010 | 12 | 0.390 |
Why?
|
| Gene Knock-In Techniques | 5 | 2017 | 171 | 0.390 |
Why?
|
| Transgenes | 4 | 2013 | 557 | 0.380 |
Why?
|
| Huntington Disease | 3 | 2007 | 135 | 0.380 |
Why?
|
| Calcium | 1 | 2017 | 1537 | 0.380 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 208 | 0.370 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2022 | 413 | 0.370 |
Why?
|
| Brain Diseases | 3 | 2020 | 403 | 0.370 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2021 | 245 | 0.360 |
Why?
|
| Spiral Ganglion | 1 | 2009 | 11 | 0.360 |
Why?
|
| Proprioception | 1 | 2009 | 21 | 0.360 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 376 | 0.360 |
Why?
|
| Merkel Cells | 1 | 2009 | 7 | 0.360 |
Why?
|
| History, 20th Century | 4 | 2019 | 574 | 0.350 |
Why?
|
| Codon, Nonsense | 2 | 2020 | 164 | 0.350 |
Why?
|
| DNA Repeat Expansion | 3 | 2007 | 64 | 0.350 |
Why?
|
| Computational Biology | 6 | 2020 | 1271 | 0.350 |
Why?
|
| Hearing | 1 | 2009 | 64 | 0.350 |
Why?
|
| Neurology | 2 | 2013 | 113 | 0.350 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 313 | 0.350 |
Why?
|
| Hyperkinesis | 2 | 2013 | 23 | 0.350 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 43 | 0.350 |
Why?
|
| Arousal | 1 | 2009 | 120 | 0.350 |
Why?
|
| Touch | 1 | 2009 | 71 | 0.340 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 269 | 0.340 |
Why?
|
| Rotarod Performance Test | 6 | 2021 | 26 | 0.340 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2018 | 518 | 0.330 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 173 | 0.330 |
Why?
|
| Exercise Therapy | 1 | 2011 | 288 | 0.330 |
Why?
|
| Appetite Regulation | 1 | 2008 | 41 | 0.320 |
Why?
|
| Calcium Channels, N-Type | 1 | 2008 | 39 | 0.320 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 554 | 0.320 |
Why?
|
| Genome | 3 | 2018 | 672 | 0.320 |
Why?
|
| Homeodomain Proteins | 8 | 2014 | 1143 | 0.320 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2008 | 27 | 0.320 |
Why?
|
| Somatomedins | 1 | 2008 | 75 | 0.310 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 35 | 0.310 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 14551 | 0.310 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2016 | 159 | 0.310 |
Why?
|
| Ataxia | 3 | 2018 | 176 | 0.310 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 21 | 0.310 |
Why?
|
| Animals, Newborn | 7 | 2021 | 1338 | 0.310 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 66 | 0.300 |
Why?
|
| COUP Transcription Factor I | 2 | 2020 | 81 | 0.300 |
Why?
|
| Morphogenesis | 1 | 2008 | 337 | 0.300 |
Why?
|
| Nervous System Malformations | 2 | 2006 | 133 | 0.300 |
Why?
|
| Antimanic Agents | 1 | 2007 | 39 | 0.300 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 424 | 0.300 |
Why?
|
| Protein Methyltransferases | 2 | 2007 | 45 | 0.290 |
Why?
|
| Molecular Sequence Data | 9 | 2016 | 6089 | 0.290 |
Why?
|
| Two-Hybrid System Techniques | 6 | 2011 | 189 | 0.290 |
Why?
|
| Child | 15 | 2020 | 29154 | 0.280 |
Why?
|
| Integrases | 2 | 2020 | 262 | 0.280 |
Why?
|
| Gene Targeting | 5 | 2020 | 292 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 1265 | 0.280 |
Why?
|
| Physicians | 1 | 2015 | 882 | 0.280 |
Why?
|
| Molecular Chaperones | 3 | 2007 | 264 | 0.280 |
Why?
|
| Glutamic Acid | 4 | 2009 | 309 | 0.280 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2005 | 21 | 0.280 |
Why?
|
| Fear | 5 | 2016 | 254 | 0.280 |
Why?
|
| Drosophila Proteins | 4 | 2016 | 858 | 0.270 |
Why?
|
| Biomarkers | 7 | 2022 | 5047 | 0.270 |
Why?
|
| Syndrome | 4 | 2018 | 1351 | 0.270 |
Why?
|
| Ataxin-7 | 6 | 2011 | 22 | 0.270 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 417 | 0.270 |
Why?
|
| Age of Onset | 3 | 2018 | 827 | 0.270 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 323 | 0.270 |
Why?
|
| Academies and Institutes | 2 | 2019 | 95 | 0.260 |
Why?
|
| Down-Regulation | 6 | 2013 | 2074 | 0.260 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1516 | 0.260 |
Why?
|
| Green Fluorescent Proteins | 6 | 2013 | 694 | 0.260 |
Why?
|
| Cerebellar Neoplasms | 1 | 2009 | 434 | 0.260 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 3869 | 0.250 |
Why?
|
| Genotype | 8 | 2020 | 4109 | 0.250 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2011 | 362 | 0.250 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2009 | 81 | 0.250 |
Why?
|
| Presynaptic Terminals | 2 | 2018 | 114 | 0.250 |
Why?
|
| Blotting, Western | 8 | 2015 | 3536 | 0.240 |
Why?
|
| Conserved Sequence | 2 | 2021 | 469 | 0.240 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 311 | 0.240 |
Why?
|
| Electroencephalography | 4 | 2018 | 898 | 0.240 |
Why?
|
| Multiprotein Complexes | 2 | 2022 | 395 | 0.240 |
Why?
|
| Cell Cycle | 3 | 2023 | 2084 | 0.240 |
Why?
|
| Respiration | 3 | 2018 | 447 | 0.240 |
Why?
|
| Caspases | 1 | 2006 | 661 | 0.240 |
Why?
|
| Lithium | 2 | 2013 | 71 | 0.230 |
Why?
|
| Spatial Learning | 2 | 2021 | 16 | 0.230 |
Why?
|
| Research | 1 | 2006 | 415 | 0.230 |
Why?
|
| DNA | 4 | 2015 | 2693 | 0.230 |
Why?
|
| PubMed | 1 | 2023 | 41 | 0.230 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 129 | 0.230 |
Why?
|
| Action Potentials | 3 | 2021 | 560 | 0.230 |
Why?
|
| Animals, Genetically Modified | 5 | 2013 | 406 | 0.230 |
Why?
|
| Growth Differentiation Factors | 1 | 2023 | 13 | 0.230 |
Why?
|
| Time Factors | 7 | 2021 | 12926 | 0.230 |
Why?
|
| Regulatory Factor X1 | 1 | 2022 | 8 | 0.230 |
Why?
|
| Embryonic Development | 1 | 2005 | 306 | 0.230 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 40 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2006 | 492 | 0.230 |
Why?
|
| Binding Sites | 5 | 2021 | 2171 | 0.230 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 677 | 0.220 |
Why?
|
| Exons | 3 | 2016 | 1328 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2016 | 1062 | 0.220 |
Why?
|
| Methylation | 2 | 2019 | 597 | 0.220 |
Why?
|
| Child, Preschool | 11 | 2020 | 16273 | 0.220 |
Why?
|
| Diptera | 1 | 2002 | 26 | 0.220 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2013 | 48 | 0.210 |
Why?
|
| Chromosomal Instability | 1 | 2003 | 233 | 0.210 |
Why?
|
| Phosphoproteins | 2 | 2007 | 1152 | 0.210 |
Why?
|
| In Situ Hybridization | 5 | 2010 | 1037 | 0.210 |
Why?
|
| Models, Biological | 8 | 2022 | 3254 | 0.210 |
Why?
|
| Transglutaminases | 1 | 2022 | 99 | 0.210 |
Why?
|
| In Vitro Techniques | 5 | 2009 | 1618 | 0.210 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 6009 | 0.200 |
Why?
|
| Memory, Long-Term | 1 | 2022 | 39 | 0.200 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 137 | 0.200 |
Why?
|
| Neuroglia | 2 | 2016 | 223 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 2508 | 0.200 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2023 | 268 | 0.200 |
Why?
|
| Base Sequence | 4 | 2018 | 4917 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 1439 | 0.200 |
Why?
|
| Stress, Psychological | 1 | 2008 | 1000 | 0.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2015 | 176 | 0.200 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2019 | 83 | 0.200 |
Why?
|
| X Chromosome Inactivation | 3 | 2012 | 73 | 0.190 |
Why?
|
| Dendrites | 3 | 2013 | 196 | 0.190 |
Why?
|
| Psychomotor Performance | 2 | 2021 | 233 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 651 | 0.190 |
Why?
|
| Cell Nucleolus | 1 | 2020 | 89 | 0.190 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 534 | 0.180 |
Why?
|
| Perirhinal Cortex | 1 | 2019 | 2 | 0.180 |
Why?
|
| Genes, Dominant | 3 | 2014 | 331 | 0.180 |
Why?
|
| Glutamine | 3 | 2008 | 299 | 0.180 |
Why?
|
| Cholinergic Neurons | 1 | 2019 | 18 | 0.180 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 39 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2015 | 323 | 0.180 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 5 | 0.180 |
Why?
|
| Central Nervous System | 1 | 2002 | 436 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 3639 | 0.180 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 30 | 0.180 |
Why?
|
| LIM-Homeodomain Proteins | 3 | 2011 | 95 | 0.180 |
Why?
|
| Evolution, Molecular | 3 | 2018 | 834 | 0.180 |
Why?
|
| Models, Neurological | 1 | 2021 | 225 | 0.180 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 275 | 0.180 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 35 | 0.180 |
Why?
|
| Protein Phosphatase 2 | 2 | 2017 | 88 | 0.170 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 13 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2009 | 2054 | 0.170 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2012 | 101 | 0.170 |
Why?
|
| Models, Genetic | 4 | 2007 | 1113 | 0.170 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 99 | 0.170 |
Why?
|
| Cell Division | 1 | 2023 | 2489 | 0.170 |
Why?
|
| Genome, Human | 2 | 2021 | 1869 | 0.170 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 1084 | 0.170 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 7548 | 0.170 |
Why?
|
| Lysosomes | 1 | 2021 | 347 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 181 | 0.170 |
Why?
|
| Spermatozoa | 2 | 2020 | 315 | 0.170 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 672 | 0.160 |
Why?
|
| Base Pairing | 1 | 2018 | 68 | 0.160 |
Why?
|
| Prosencephalon | 1 | 2018 | 43 | 0.160 |
Why?
|
| Hypoglossal Nerve | 1 | 2018 | 6 | 0.160 |
Why?
|
| Mosaicism | 2 | 2020 | 272 | 0.160 |
Why?
|
| Mice, Neurologic Mutants | 4 | 2007 | 80 | 0.160 |
Why?
|
| Spatial Memory | 1 | 2018 | 41 | 0.160 |
Why?
|
| Spliceosomes | 1 | 2018 | 75 | 0.160 |
Why?
|
| Gliosis | 1 | 2018 | 41 | 0.160 |
Why?
|
| Immunoprecipitation | 4 | 2015 | 591 | 0.160 |
Why?
|
| Uncertainty | 1 | 2020 | 320 | 0.160 |
Why?
|
| Membrane Potentials | 2 | 2017 | 424 | 0.160 |
Why?
|
| Protein Aggregates | 1 | 2018 | 27 | 0.160 |
Why?
|
| Cell Survival | 2 | 2018 | 3045 | 0.160 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 38 | 0.160 |
Why?
|
| Caffeine | 1 | 2018 | 87 | 0.160 |
Why?
|
| Embryo, Mammalian | 4 | 2011 | 741 | 0.160 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 170 | 0.160 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 90 | 0.150 |
Why?
|
| Genomic Imprinting | 2 | 2013 | 194 | 0.150 |
Why?
|
| Pedigree | 3 | 2018 | 1890 | 0.150 |
Why?
|
| Nuclear Localization Signals | 2 | 2015 | 46 | 0.150 |
Why?
|
| Pars Compacta | 1 | 2017 | 4 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 246 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 234 | 0.150 |
Why?
|
| Oocytes | 1 | 2020 | 414 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2019 | 176 | 0.150 |
Why?
|
| Recombination, Genetic | 1 | 2020 | 613 | 0.150 |
Why?
|
| Proteins | 1 | 2005 | 1963 | 0.150 |
Why?
|
| Motor Cortex | 1 | 2018 | 117 | 0.150 |
Why?
|
| Antigens, Ly | 2 | 2015 | 49 | 0.150 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 49 | 0.150 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 126 | 0.150 |
Why?
|
| Age Factors | 5 | 2013 | 5377 | 0.150 |
Why?
|
| Infant | 7 | 2018 | 13310 | 0.150 |
Why?
|
| Models, Molecular | 3 | 2016 | 1732 | 0.150 |
Why?
|
| Transfection | 6 | 2008 | 2944 | 0.150 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 31 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2016 | 844 | 0.140 |
Why?
|
| Diaphragm | 1 | 2018 | 181 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 470 | 0.140 |
Why?
|
| Meningioma | 1 | 2019 | 289 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2018 | 220 | 0.140 |
Why?
|
| Adolescent | 9 | 2020 | 31252 | 0.140 |
Why?
|
| Reflex, Startle | 3 | 2012 | 65 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 218 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 492 | 0.140 |
Why?
|
| Gene Rearrangement | 2 | 2011 | 783 | 0.140 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.140 |
Why?
|
| Stereotyped Behavior | 1 | 2015 | 35 | 0.140 |
Why?
|
| History, 21st Century | 2 | 2019 | 441 | 0.140 |
Why?
|
| COS Cells | 6 | 2008 | 377 | 0.140 |
Why?
|
| Rats | 2 | 2019 | 6086 | 0.130 |
Why?
|
| Sensation | 1 | 2015 | 71 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2011 | 2283 | 0.130 |
Why?
|
| Photoreceptor Cells | 2 | 2006 | 75 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 441 | 0.130 |
Why?
|
| Ubiquitin | 3 | 2006 | 344 | 0.130 |
Why?
|
| Trans-Activators | 4 | 2011 | 1555 | 0.130 |
Why?
|
| Protein Transport | 4 | 2022 | 734 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 644 | 0.130 |
Why?
|
| Immunoblotting | 1 | 2016 | 886 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 276 | 0.130 |
Why?
|
| Maze Learning | 2 | 2007 | 132 | 0.130 |
Why?
|
| France | 1 | 2014 | 108 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2022 | 1154 | 0.120 |
Why?
|
| Friedreich Ataxia | 2 | 2005 | 40 | 0.120 |
Why?
|
| Lac Operon | 2 | 2005 | 122 | 0.120 |
Why?
|
| Liver | 2 | 2015 | 2961 | 0.120 |
Why?
|
| Lip | 1 | 2014 | 33 | 0.120 |
Why?
|
| Genetic Engineering | 2 | 2008 | 288 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 848 | 0.120 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2014 | 21 | 0.120 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2014 | 35 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 666 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 3203 | 0.120 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 16 | 0.120 |
Why?
|
| Software | 2 | 2020 | 1321 | 0.120 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 126 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 2488 | 0.120 |
Why?
|
| Chromosome Mapping | 3 | 2013 | 1471 | 0.120 |
Why?
|
| Optic Atrophy | 1 | 2014 | 46 | 0.120 |
Why?
|
| Point Mutation | 2 | 2014 | 769 | 0.120 |
Why?
|
| RNA | 4 | 2005 | 1013 | 0.120 |
Why?
|
| Heterozygote | 2 | 2020 | 1020 | 0.110 |
Why?
|
| Pregnancy | 3 | 2012 | 7573 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 169 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2013 | 106 | 0.110 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 998 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 810 | 0.110 |
Why?
|
| Pancreas | 1 | 2016 | 718 | 0.110 |
Why?
|
| X-linked Nuclear Protein | 1 | 2013 | 56 | 0.110 |
Why?
|
| Heterochromatin | 1 | 2013 | 83 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 671 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 246 | 0.110 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 162 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2019 | 1171 | 0.110 |
Why?
|
| Family Health | 2 | 2014 | 325 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2013 | 106 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 2 | 2003 | 205 | 0.110 |
Why?
|
| Genetic Linkage | 3 | 2005 | 512 | 0.110 |
Why?
|
| Solubility | 2 | 2003 | 242 | 0.110 |
Why?
|
| Protein Structure, Quaternary | 2 | 2013 | 138 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 441 | 0.110 |
Why?
|
| Adult | 7 | 2023 | 77950 | 0.110 |
Why?
|
| Valproic Acid | 1 | 2013 | 263 | 0.110 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 3 | 2021 | 25 | 0.100 |
Why?
|
| CpG Islands | 1 | 2014 | 633 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 6 | 2016 | 3101 | 0.100 |
Why?
|
| Dimerization | 2 | 2013 | 304 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2007 | 854 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2014 | 1053 | 0.100 |
Why?
|
| Histone Acetyltransferases | 2 | 2011 | 411 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2012 | 250 | 0.100 |
Why?
|
| Body Weight | 3 | 2020 | 1293 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 2216 | 0.100 |
Why?
|
| Neural Pathways | 2 | 2010 | 298 | 0.100 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2010 | 17 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 123 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 110 | 0.100 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 85 | 0.100 |
Why?
|
| Organogenesis | 1 | 2011 | 119 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 32 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 44 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 1879 | 0.100 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 36 | 0.100 |
Why?
|
| Actins | 1 | 2013 | 608 | 0.090 |
Why?
|
| Disease Progression | 6 | 2019 | 6682 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 28 | 0.090 |
Why?
|
| Metabolome | 1 | 2013 | 344 | 0.090 |
Why?
|
| Protein Kinase C-delta | 1 | 2010 | 42 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2013 | 434 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2016 | 7226 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2011 | 107 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2010 | 126 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2008 | 250 | 0.090 |
Why?
|
| Homovanillic Acid | 1 | 2009 | 21 | 0.090 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2009 | 25 | 0.090 |
Why?
|
| Auditory Pathways | 1 | 2009 | 18 | 0.090 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2009 | 30 | 0.090 |
Why?
|
| Proteome | 3 | 2017 | 561 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 360 | 0.090 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.090 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 54 | 0.090 |
Why?
|
| Smoothened Receptor | 1 | 2009 | 52 | 0.090 |
Why?
|
| Mice, Congenic | 1 | 2009 | 30 | 0.090 |
Why?
|
| Cochlear Nucleus | 1 | 2009 | 5 | 0.090 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 39 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1715 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2009 | 35 | 0.090 |
Why?
|
| Precipitin Tests | 3 | 2007 | 329 | 0.090 |
Why?
|
| Acetylcholine | 1 | 2009 | 96 | 0.090 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 45 | 0.090 |
Why?
|
| Levodopa | 1 | 2009 | 92 | 0.090 |
Why?
|
| Amines | 1 | 2009 | 85 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 1380 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2010 | 197 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 118 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1165 | 0.090 |
Why?
|
| Crosses, Genetic | 2 | 2008 | 241 | 0.090 |
Why?
|
| Fetus | 1 | 2013 | 601 | 0.090 |
Why?
|
| Macular Degeneration | 1 | 2010 | 114 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 107 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2015 | 289 | 0.090 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 414 | 0.090 |
Why?
|
| Medical Records | 1 | 2010 | 415 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 3890 | 0.080 |
Why?
|
| Foot | 1 | 2009 | 104 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2012 | 8223 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 69 | 0.080 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2008 | 24 | 0.080 |
Why?
|
| Phenylalanine | 1 | 2008 | 142 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 2291 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 394 | 0.080 |
Why?
|
| Gene Ontology | 2 | 2020 | 80 | 0.080 |
Why?
|
| Protein Folding | 2 | 2006 | 281 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 664 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 270 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 521 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2008 | 163 | 0.080 |
Why?
|
| Transcription Factor 4 | 1 | 2007 | 36 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2017 | 2483 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 194 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 211 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2008 | 267 | 0.070 |
Why?
|
| Tropomodulin | 2 | 2003 | 2 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 417 | 0.070 |
Why?
|
| Caspase 6 | 1 | 2006 | 15 | 0.070 |
Why?
|
| Wings, Animal | 1 | 2006 | 62 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 163 | 0.070 |
Why?
|
| United States | 4 | 2022 | 15433 | 0.070 |
Why?
|
| Nerve Net | 1 | 2009 | 257 | 0.070 |
Why?
|
| Homozygote | 2 | 2020 | 717 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 1242 | 0.070 |
Why?
|
| Adiposity | 1 | 2008 | 237 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 343 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 161 | 0.070 |
Why?
|
| CHO Cells | 4 | 2011 | 311 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 2522 | 0.070 |
Why?
|
| Huntingtin Protein | 1 | 2006 | 60 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 161 | 0.070 |
Why?
|
| Ileum | 1 | 2007 | 165 | 0.070 |
Why?
|
| Aggression | 1 | 2008 | 252 | 0.070 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2006 | 84 | 0.070 |
Why?
|
| Inclusion Bodies | 2 | 2003 | 76 | 0.070 |
Why?
|
| Cerebellar Ataxia | 1 | 2007 | 72 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 488 | 0.070 |
Why?
|
| Eye Abnormalities | 1 | 2006 | 118 | 0.070 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 392 | 0.070 |
Why?
|
| Peyer's Patches | 1 | 2005 | 30 | 0.070 |
Why?
|
| Zebrafish | 1 | 2008 | 463 | 0.070 |
Why?
|
| Cricetinae | 4 | 2011 | 706 | 0.070 |
Why?
|
| Ear | 1 | 2005 | 38 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2009 | 644 | 0.070 |
Why?
|
| Glycoside Hydrolases | 1 | 2005 | 37 | 0.070 |
Why?
|
| Calbindins | 3 | 2013 | 21 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2006 | 1258 | 0.070 |
Why?
|
| Apoptosis | 3 | 2016 | 7591 | 0.070 |
Why?
|
| S100 Calcium Binding Protein G | 3 | 2013 | 50 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2007 | 246 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2006 | 303 | 0.070 |
Why?
|
| Organ Size | 1 | 2007 | 690 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 1178 | 0.070 |
Why?
|
| Cochlea | 1 | 2005 | 102 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2008 | 584 | 0.060 |
Why?
|
| Tyrosine | 1 | 2006 | 498 | 0.060 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 54 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 360 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 997 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2005 | 589 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 144 | 0.060 |
Why?
|
| Chromatography, Gel | 2 | 2015 | 157 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 156 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 301 | 0.060 |
Why?
|
| Goblet Cells | 1 | 2005 | 135 | 0.060 |
Why?
|
| Fetal Viability | 1 | 2004 | 29 | 0.060 |
Why?
|
| Neuregulins | 1 | 2003 | 8 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 769 | 0.060 |
Why?
|
| Myofibrils | 1 | 2003 | 31 | 0.060 |
Why?
|
| Survival Rate | 3 | 2020 | 12221 | 0.060 |
Why?
|
| Embryo Loss | 1 | 2003 | 42 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1070 | 0.060 |
Why?
|
| Pediatrics | 1 | 2013 | 1141 | 0.060 |
Why?
|
| Myotonic Dystrophy | 1 | 2005 | 151 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 764 | 0.060 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2003 | 28 | 0.060 |
Why?
|
| Muscular Disorders, Atrophic | 1 | 2003 | 1 | 0.060 |
Why?
|
| Skin | 1 | 2009 | 1259 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2007 | 499 | 0.060 |
Why?
|
| Risk Factors | 1 | 2020 | 17523 | 0.060 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 77 | 0.060 |
Why?
|
| Muscle Spasticity | 1 | 2003 | 74 | 0.060 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2003 | 45 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 1282 | 0.060 |
Why?
|
| Gene Library | 1 | 2003 | 294 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2330 | 0.050 |
Why?
|
| Angelman Syndrome | 1 | 2003 | 78 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2003 | 67 | 0.050 |
Why?
|
| Lung | 2 | 2005 | 3151 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2003 | 200 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 132 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2005 | 560 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2008 | 808 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 330 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 575 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2003 | 79 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 591 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 2403 | 0.050 |
Why?
|
| Fetal Death | 1 | 2002 | 113 | 0.050 |
Why?
|
| Microtubules | 1 | 2003 | 270 | 0.050 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 1 | 2021 | 14 | 0.050 |
Why?
|
| Vocalization, Animal | 1 | 2021 | 25 | 0.050 |
Why?
|
| Cognition Disorders | 2 | 2020 | 786 | 0.050 |
Why?
|
| Germ Cells | 2 | 2020 | 335 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 29902 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2002 | 257 | 0.050 |
Why?
|
| Phylogeny | 1 | 2004 | 826 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 663 | 0.050 |
Why?
|
| Dystonia | 1 | 2003 | 163 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2003 | 165 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 2450 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 10035 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2003 | 380 | 0.050 |
Why?
|
| Neutropenia | 1 | 2005 | 968 | 0.050 |
Why?
|
| Epilepsy | 2 | 2020 | 883 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2011 | 1643 | 0.050 |
Why?
|
| Acetylation | 1 | 2002 | 508 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 332 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 257 | 0.050 |
Why?
|
| Protein Multimerization | 1 | 2021 | 240 | 0.050 |
Why?
|
| Interdisciplinary Communication | 1 | 2002 | 280 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2006 | 1960 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 875 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2002 | 351 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2002 | 382 | 0.050 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 2 | 0.050 |
Why?
|
| Hindlimb | 1 | 2020 | 105 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 314 | 0.050 |
Why?
|
| Genes, Lethal | 1 | 2020 | 120 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2015 | 2307 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 627 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 676 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2013 | 388 | 0.040 |
Why?
|
| Optogenetics | 1 | 2019 | 48 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2013 | 426 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 2 | 2011 | 29 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 339 | 0.040 |
Why?
|
| Amino Acids | 1 | 2002 | 728 | 0.040 |
Why?
|
| Cricetulus | 2 | 2011 | 205 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 351 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 65 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 260 | 0.040 |
Why?
|
| RNA, Nuclear | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 110 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1694 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 218 | 0.040 |
Why?
|
| Topotecan | 1 | 2018 | 239 | 0.040 |
Why?
|
| Sumoylation | 1 | 2018 | 84 | 0.040 |
Why?
|
| Bias | 1 | 2018 | 205 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 777 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 1223 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2013 | 699 | 0.040 |
Why?
|
| Endocrine System | 1 | 2016 | 36 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 231 | 0.040 |
Why?
|
| Gene Editing | 1 | 2019 | 216 | 0.040 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2016 | 4 | 0.040 |
Why?
|
| Oxadiazoles | 1 | 2016 | 57 | 0.040 |
Why?
|
| Anemia | 1 | 2002 | 689 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 1678 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2016 | 385 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 1163 | 0.040 |
Why?
|
| Cholecystokinin | 1 | 2016 | 45 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 2218 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2016 | 36 | 0.040 |
Why?
|
| Imaginal Discs | 1 | 2016 | 12 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 624 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5395 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 154 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2015 | 50 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 745 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 2803 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 376 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 290 | 0.030 |
Why?
|
| RNA Stability | 1 | 2015 | 125 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 86204 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 118 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 154 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 279 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 301 | 0.030 |
Why?
|
| Genomics | 1 | 2005 | 2738 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2008 | 842 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 95 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 68 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 2086 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 2014 | 180 | 0.030 |
Why?
|
| Leishmania major | 1 | 2012 | 21 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 1005 | 0.030 |
Why?
|
| Young Adult | 3 | 2019 | 21445 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 205 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 644 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.030 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2012 | 46 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 423 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9180 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2013 | 149 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2012 | 94 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 1489 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 611 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2011 | 48 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 1555 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 829 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2013 | 249 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2013 | 157 | 0.030 |
Why?
|
| Research Report | 1 | 2012 | 144 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 1616 | 0.020 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 242 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2011 | 37 | 0.020 |
Why?
|
| Texas | 1 | 2002 | 6311 | 0.020 |
Why?
|
| Microcephaly | 1 | 2014 | 325 | 0.020 |
Why?
|
| Electroporation | 1 | 2011 | 126 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 923 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 298 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 459 | 0.020 |
Why?
|
| Ataxin-10 | 1 | 2010 | 19 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 4971 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2015 | 1234 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 383 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 30 | 0.020 |
Why?
|
| Metabolomics | 1 | 2013 | 478 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2009 | 51 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 13 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 86 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2009 | 105 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 968 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 39 | 0.020 |
Why?
|
| Weight Gain | 1 | 2012 | 464 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 1399 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 432 | 0.020 |
Why?
|
| Alanine | 1 | 2009 | 240 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 1144 | 0.020 |
Why?
|
| Nesting Behavior | 1 | 2008 | 14 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1239 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 220 | 0.020 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 234 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2007 | 21 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cerebellar Cortex | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2007 | 76 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2007 | 104 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 87 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7702 | 0.020 |
Why?
|
| Amygdala | 1 | 2008 | 127 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 4549 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2006 | 40 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 55 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 184 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 100 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 3033 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 445 | 0.020 |
Why?
|
| Medicare | 1 | 2010 | 860 | 0.020 |
Why?
|
| Octoxynol | 1 | 2005 | 11 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 2809 | 0.020 |
Why?
|
| Detergents | 1 | 2005 | 34 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 2265 | 0.020 |
Why?
|
| Contig Mapping | 1 | 2005 | 61 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 53 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 56 | 0.020 |
Why?
|
| Centromere | 1 | 2005 | 97 | 0.020 |
Why?
|
| Blood Viscosity | 1 | 1974 | 23 | 0.020 |
Why?
|
| Rheology | 1 | 1974 | 55 | 0.020 |
Why?
|
| Homer Scaffolding Proteins | 1 | 2004 | 4 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2004 | 28 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2004 | 114 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 354 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2005 | 119 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 208 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 63 | 0.020 |
Why?
|
| Actinin | 1 | 2003 | 21 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 2352 | 0.020 |
Why?
|
| Connectin | 1 | 2003 | 30 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 143 | 0.010 |
Why?
|
| Biological Assay | 1 | 2005 | 177 | 0.010 |
Why?
|
| Autoantigens | 1 | 2005 | 234 | 0.010 |
Why?
|
| Doxycycline | 1 | 2004 | 178 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 214 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 216 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 213 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 1213 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 251 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 169 | 0.010 |
Why?
|
| Inferior Colliculi | 1 | 2002 | 4 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 837 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 94 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2003 | 139 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 422 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 270 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 139 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 185 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 698 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 291 | 0.010 |
Why?
|
| Choristoma | 1 | 2002 | 85 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 359 | 0.010 |
Why?
|
| Conditioning, Classical | 1 | 2002 | 69 | 0.010 |
Why?
|
| Leukocytes | 1 | 2004 | 422 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 145 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2002 | 406 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 621 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 508 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2007 | 686 | 0.010 |
Why?
|
| DNA Repair | 1 | 2009 | 1872 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 315 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 717 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 383 | 0.010 |
Why?
|
| Gestational Age | 1 | 2003 | 1069 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2003 | 549 | 0.010 |
Why?
|
| Pain | 1 | 2008 | 1658 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 862 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1506 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 1756 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 1313 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 1823 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 70117 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 3230 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 37905 | 0.010 |
Why?
|
| Transistors, Electronic | 1 | 1974 | 7 | 0.000 |
Why?
|